Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$209.38 - $283.47
Previous CloseN/A
Volume103.18K
Average Volume (3M)756.06K
Market Cap
$22.38B
Enterprise Value$27.94B
Total Cash (Recent Filing)$647.30M
Total Debt (Recent Filing)$6.55B
Price to Earnings (P/E)29.7
Beta0.43
Next Earnings
Oct 23, 2025EPS Estimate
4.12Next Dividend Ex-Date
Aug 28, 2025Dividend Yield1.06%
Share Statistics
EPS (TTM)4.35
Shares Outstanding83,100,000
10 Day Avg. Volume566,278
30 Day Avg. Volume756,060
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue2.07
Enterprise Value/Gross Profit7.36
Enterprise Value/Ebitda20.50
Forecast
1Y Price Target
$296.50Price Target Upside8.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceLabcorp Holdings Inc. raised its 2025 EPS guidance, driven partly by strong operational expectations and consistent high utilization levels.
Foreign Exchange ImpactForeign exchange tailwinds have positively impacted Labcorp's raised guidance, particularly through exposure to the Swiss franc and British pound.
Growth StrategyLabcorp expects promising organic and inorganic growth in diagnostics, supported by new acquisitions and partnerships.
Bears Say
Policy HeadwindsLabcorp Holdings Inc. faces potential policy headwinds related to PAMA resolutions, which could result in a significant financial impact if not addressed.
Revenue Volume ImpactManagement is embedding an impact from Health Insurance Exchange disenrollment, which could affect revenue volume.
Labcorp Holdings News
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $209.38 and its highest was $283.47 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $22.38B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Oct 23, 2025 which is in 70 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Jul 24, 2025. The company reported $4.35 earnings per share for the quarter, beating the consensus estimate of $4.168 by $0.182.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.06%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 4.12.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 83,100,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $4.35 in its last earnings report, beating expectations of $4.168. Following the earnings report the stock price went up 6.858%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
Labcorp Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$296.50 (8.79% Upside)
$296.50 (8.79% Upside)
Blogger Sentiment
Bullish
LH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 369.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 2.3%
Last 30 Days ▲ 6.0%
Last 30 Days ▲ 6.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.02%
12-Months-Change
Fundamentals
Return on Equity
9.27%
Trailing 12-Months
Asset Growth
8.06%
Trailing 12-Months
Company Description
Labcorp Holdings
Labcorp Holdings (LH) is a global leader in laboratory services, specializing in diagnostic testing, drug development, and related services. The company operates in two primary segments: Labcorp Diagnostics, which provides comprehensive laboratory testing services across various medical disciplines, and Labcorp Drug Development, which offers services to pharmaceutical and biotechnology companies to aid in the drug development process. With a strong focus on innovation and technology, Labcorp aims to improve patient health and advance medical science through its extensive range of tests and clinical development services.
LH Company Deck
LH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Labcorp Holdings reported strong financial performance with significant revenue growth and raised full-year guidance. However, the company faces potential challenges from PAMA cuts and regulatory uncertainties.View all LH earnings summariesLH Revenue Breakdown
77.98% Dx
22.47% BLS
LH Stock 12 Month Forecast
Average Price Target
$296.50
▲(8.79% Upside)
Technical Analysis
Ownership Overview
0.33% Insiders
28.94% Mutual Funds
1.17% Other Institutional Investors
45.47% Public Companies and
Individual Investors